Mannatech (NASDAQ:MTEX) Stock Crosses Below 200-Day Moving Average – Here’s Why

Mannatech, Incorporated (NASDAQ:MTEX) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $8.75 and traded as low as $7.19. Mannatech shares last traded at $7.40, with a volume of 7,914 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Mannatech in a research report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Mannatech presently has an average rating of “Sell”.

Mannatech Trading Up 0.4%

The firm has a market cap of $14.06 million, a PE ratio of -8.60 and a beta of 0.79. The business has a 50-day moving average price of $8.65 and a two-hundred day moving average price of $8.75. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.13 and a quick ratio of 0.56.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings data on Wednesday, November 12th. The company reported $1.01 EPS for the quarter. The business had revenue of $29.16 million for the quarter. Mannatech had a negative net margin of 1.50% and a negative return on equity of 22.75%.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.